We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Improved Antigen Test Detects Filarial Infection

By LabMedica International staff writers
Posted on 05 Jun 2013
A newly introduced diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test. More...


The immunodiagnostic test detects circulating filarial antigen (CFA) in the blood of patients with elephantiasis. It was compared to another commercial card test both in laboratory-banked samples and in fresh samples from the field.

Infectious diseases specialists at the Washington University School of Medicine (St. Louis, MO, USA) tested a panel of well-characterized serum or plasma samples for both assays in the laboratory. A field study was performed in northwestern Liberia. Blood was collected directly into a small 75-µL blood collection pipette for the Filariasis Test Strip and a 100-µL capillary tube supplied with the BinaxNOW Filariasis card test. Both test strip and card are manufactured by Alere Scarborough Inc. (Scarborough, ME, USA) and are read 10 minutes after application of the blood.

In the laboratory evaluation, the test strip produced stronger, sharper positive test lines than the card, and the test strip was more sensitive than the card test. Both tests detected filarial antigenemia in all 88 samples from subjects with Wuchereria bancrofti microfilaremia. Study participants in the field evaluation ranged in age from six to 89 years, and approximately one-half of the subjects tested were female. The sensitivity of the tests was compared for 503 blood samples that had valid results for both tests. The Filariasis test strip produced 26.5% more positive test results with 124/503 compared with 98/503 for the BinaxNOW card test.

Gary J. Weil, MD, the lead author, said, “The older test has had a major impact, but the new one is even better. Annually, medication to treat and prevent the infection is distributed to more than 500 million people worldwide. The improved sensitivity of the new test will help determine whether the mass treatment program has been effective and also identify regions that need additional attention." The new test strip also has a longer shelf life, estimated at two years without refrigeration, compared with three months for the older version, and it is expected to cost less. The study was published on May 20, 2013, in the American Journal of Tropical Medicine and Hygiene.

Related Links:

Washington University School of Medicine

Alere Scarborough Inc



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Hemoglobin Stool Test
CerTest FOB 50 + 200 One Step Combo Card Test
New
HAV Rapid Test
OnSite HAV IgG/IgM Rapid Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Ear wax could be a possible screening medium for Parkinson’s disease (Photo courtesy of 123RF)

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. Since most treatments only slow... Read more

Molecular Diagnostics

view channel
Image: A family of molecules could help diagnose and treat breast cancer (Photo courtesy of Shutterstock)

Molecular Biomarkers Pave Way for New Tests to Diagnose and Predict Breast Cancer

Despite playing essential roles in tissue development and immune protection, the contribution of proteoglycans in cancer remains poorly understood. Some proteoglycans appear to shield the body from cancer,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: T cell immunity could be a marker for early Parkinson’s treatment (Photo courtesy of Shutterstock)

T Cells in Blood Can Detect Parkinson's Years Before Diagnosis

Diagnosing Parkinson’s disease before the appearance of motor symptoms remains one of neurology’s most significant challenges. Patients can go years—even decades—without a diagnosis, as subtle early indicators... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.